Skip to content

Abu Dhabi Sleep Apnea (ADSA) Study

Abu Dhabi Sleep Apnea (ADSA) Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02403141
Acronym
ADSA
Enrollment
1400
Registered
2015-03-31
Start date
2015-03-31
Completion date
2017-03-31
Last updated
2017-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnoea

Brief summary

Obstructive sleep apnoea (OSA) is a common medical problem which, despite increasing awareness, remains under-diagnosed. There is a close association between OSA and obesity; 60-70% of patients diagnosed with OSA are either obese or overweight \[1\]. OSA is also very common among patients with type 2 diabetes. Type 2 Diabetes Mellitus (T2DM) has reached epidemic status in the Gulf region. OSA worsens insulin resistance and leads to weight gain through sleep disturbance \[2\]. Several mechanisms have been proposed for the associations of OSA with diabetes and obesity \[3\]. At present there is little available information regarding the prevalence of OSA in the UAE, the relationship with T2DM and obesity, and the impact of OSA on health outcomes in the Emirati population. This research will explore these relationships and inform public health decisions regarding diagnostic pathways, service provision and treatment protocols.

Interventions

OTHERQuestionnaire

Sponsors

Imperial College London Diabetes Centre
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

Participants aged between 18-64 years old. Both Gender male and female.

Exclusion criteria

Paediatrics below the age of 18. Any participant who is unable to take part

Design outcomes

Primary

MeasureTime frameDescription
Primary objective (Establishing the prevalence of OSA in the study population.)3 monthsEstablishing the prevalence of OSA in the study population.

Countries

United Arab Emirates

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026